|
In re Par Pharmaceutical Securities Litigation
USDC New Jersey
Restatement; FDA
Group Pleading
Background
|
Company
background
Litigation
background
- Weissmann V. Par Pharmaceutical Companies, Inc.
- USDC
D New Jersey (Newark) 06-cv-03226-PGS-ES
Lead
plaintiffs
- Snow Capital Investment Partners
- WR Capital Management, LP
|
Financial Restatement Announcement
|
Due
to understatement of accounts receivable reserves
|
Claims
|
Complaint
|
Motion to
Dismiss Granted 
SEC_CODE_REF_0090001192884
|
Company
motion to dismiss
Individual
motion to dismiss
Plaintiff
Opinion
|
Counsel
|
Lead
plaintiff
- Lerach Coughlin
- Federman & Sherwood
- Lite DePalma
Company
defense
Individual
defense
|
Related Topics
|